# Preemptive Co-infiltration of Dexamethasone Palmitate With Ropivacaine for Postoperative Pain in Major Spinal Surgery

> **NCT05693467** · PHASE4 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 124 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Dexamethasone palmitate emulsion(DXP) plus ropivacaine
- **DRUG:** Ropivacaine alone

## Key facts

- **NCT ID:** NCT05693467
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05693467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05693467, "Preemptive Co-infiltration of Dexamethasone Palmitate With Ropivacaine for Postoperative Pain in Major Spinal Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05693467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*